Facioscapulohumeral Muscular Dystrophy Type
📧 Sign up to get email alerts when something new happens for Facioscapulohumeral Muscular Dystrophy Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]
Phase 1/2 trial of AOC 1020 for facioscapulohumeral muscular dystrophy has completed enrollment; the update does not provide trial results.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1 [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating ARO-DUX4 in adults and adolescents with facioscapulohumeral muscular dystrophy type 1. The st…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings
A completed clinical trial reports ultrasound-based detection of early facial muscle changes in facioscapulohumeral muscular dystrophy, deta…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension [Phase 2]
A Phase 2 study of losmapimod for facioscapulohumeral muscular dystrophy type 1 was terminated; the sponsor has posted results outlining saf…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients [NA]
A clinical trial is currently recruiting to evaluate diaphragmatic ultrasound in patients with Facioscapulohumeral muscular dystrophy type 1…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1 [Phase 2]
Phase 2 study evaluating the efficacy and safety of satralizumab in facioscapulohumeral muscular dystrophy type 1. The trial is currently ac…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression [NA]
This document describes an 18-month prospective natural history study to gain insight into FSHD2 pathophysiology and disease progression. Th…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: A Registered Cohort Study on FSHD1
A registered cohort study investigating Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is currently recruiting participants.